Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection
Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection
复制标题
DOI：
10.1093/jpids/piz041
复制
发表时间：
2020-07-01
影响因子：
3.2
通讯作者：
Aziz, Hossam Abdel
中科院分区：
文献类型：
--
作者：
Fouad, Hanan M.;Sabry, Magda A.;Aziz, Hossam Abdel
我们评估了ledipasvir-sofosbuvir治疗埃及青少年丙型肝炎病毒感染的安全性和有效性，并将结果与品牌形式的治疗结果进行了比较。通用形式导致高响应率，肝功能显著改善和轻度不良反应。这些结果与品牌形式的价格降低的结果相当。
We assessed the safety and efficacy of a generic form of ledipasvir-sofosbuvir for the treatment of hepatitis C virus infection in Egyptian adolescents and compared the results with those of treatment with the brand-named form. The generic form resulted in a high response rate, significant improvement in liver function, and mild adverse effects. These results are comparable with those of the brand form at a reduced price.